Adjuvanted recombinant HBV vaccine (HBV-AS04) is effective over extended follow-up in dialysis population. An open-label non randomized trial-Reference-Cited by-同舟云学术

Adjuvanted recombinant HBV vaccine (HBV-AS04) is effective over extended follow-up in dialysis population. An open-label non randomized trial

Published:2020-11 Issue:6 Volume:44 Page:905-912
ISSN:2210-7401
Container-title:Clinics and Research in Hepatology and Gastroenterology
language:en
Short-container-title:Clinics and Research in Hepatology and Gastroenterology

Author:

Fabrizi Fabrizio,Cerutti Roberta,Garcia-Agudo Rebeca,Bellincioni Cecilia,Porata Giulia,Frontini Giulia,Aoufi-Rabih Sami,Messa Piergiorgio

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference45 articles.

1. National surveillance of dialysis associated diseases in the United States, 2002;Finelli;Semin Dial,2005

2. Review article: Hepatitis B and dialysis;Edey;Nephrology (Carlton),2010

3. The decades-long fight against HBV transmission to dialysis patients: slow but definite progress;Labriola;Nephrol Dial Transplant,2010

4. Investigadores del estudio PIBHE Spanish multicentre PIBHE study: Prevalence ad immunization of chronic hepatitis B in haemodialysis patients in Spain;Garcia-Agudo;Nefrologia,2016

5. Working Group of the federal steering committee for the prevention of healthcare-associated infections in end-stage renal disease facilities, National agenda for prevention of healthcare-associated infections in dialysis centers;Gupta;Semin Dial,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatitis B Vaccine: Four Decades on;Vaccines;2024-04-18

2. Comparison of homologous and heterologous inactivated and mRNA vaccination programme against SARS‐CoV‐2 in dialysis patients;Nephrology;2024-03-14

3. Nanotechnology in vaccines and personalized medicine;Comprehensive Precision Medicine;2024

4. TLR agonists as vaccine adjuvants in the prevention of viral infections: an overview;Frontiers in Microbiology;2023-12-21

5. 30-Year Development of Inactivated Virus Vaccine in China;Pharmaceutics;2023-12-02